ResearcherMashhad University of Medical SciencesActive in the last 2 years
Majid Ghayour‐Mobarhan
Matched on ORCID iD 0000-0002-1081-6754; OpenAlex author ID A5100611777. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2014: 2 papers · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 7
- Microbiome as a biomarker and therapeutic target in pancreatic cancer. Co-author DOI 10.1186/s12866-023-03166-4↗
- Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1038/s41598-023-42928-y↗
- Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Co-author DOI 10.1002/jcp.25798↗
- Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. Co-author DOI 10.2174/0929867324666170206142658↗
- Pharmacogenomic modeling in pancreatic cancer—letter. Co-author DOI 10.1158/1078-0432.ccr-14-2951↗
- AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. Co-author DOI 10.1371/journal.pone.0108057↗
- EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies. Last author DOI 10.2174/1389450115666141125123003↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Amir Avan · 5 shared papers, 2015–2024 · strength 0.54
- Paper Microbiome as a biomarker and therapeutic target in pancreatic cancer. DOI 10.1186/s12866-023-03166-4↗
- Paper Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. DOI 10.1038/s41598-023-42928-y↗
- Paper Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. DOI 10.1002/jcp.25798↗
- Majid Khazaei · 3 shared papers, 2017–2024 · strength 0.40
- Paper Microbiome as a biomarker and therapeutic target in pancreatic cancer. DOI 10.1186/s12866-023-03166-4↗
- Paper Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. DOI 10.1038/s41598-023-42928-y↗
- Paper Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. DOI 10.1002/jcp.25798↗
- Gordon A. Ferns · 3 shared papers, 2017–2024 · strength 0.40
- Paper Microbiome as a biomarker and therapeutic target in pancreatic cancer. DOI 10.1186/s12866-023-03166-4↗
- Paper Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer. DOI 10.1038/s41598-023-42928-y↗
- Paper Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. DOI 10.2174/0929867324666170206142658↗
- Ghazaleh Pourali · 2 shared papers, 2023–2024 · strength 0.32
- Mina Maftouh · 4 shared papers, 2014–2017 · strength 0.25
- Paper Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. DOI 10.1002/jcp.25798↗
- Paper Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer. DOI 10.2174/0929867324666170206142658↗
- Paper Pharmacogenomic modeling in pancreatic cancer—letter. DOI 10.1158/1078-0432.ccr-14-2951↗
- Elisa Giovannetti · 2 shared papers, 2014–2023 · strength 0.18
- Zahra Yousefli · 1 shared paper, 2023 · strength 0.14
- Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2023 · strength 0.14
- Alfred King-yin Lam · 1 shared paper, 2023 · strength 0.14
- Abolfazl Avan · 2 shared papers, 2014–2015 · strength 0.10
- Amir Avan · 2 shared papers, 2014 · strength 0.09
- Afsane Bahrami · 1 shared paper, 2017 · strength 0.08
- Mina Hosseini · 1 shared paper, 2017 · strength 0.07
- Safieh Ebrahimi · 1 shared paper, 2017 · strength 0.07
- Sharareh Gholamin · 1 shared paper, 2015 · strength 0.06
- Reza Nedaeinia · 1 shared paper, 2014 · strength 0.06
- Andrea Mambrini · 1 shared paper, 2014 · strength 0.04
- Maurizio Cantore · 1 shared paper, 2014 · strength 0.04
- Tessa Y. S. Le Large · 1 shared paper, 2014 · strength 0.04
- Niccola Funel · 1 shared paper, 2014 · strength 0.04
- Ugo Boggi · 1 shared paper, 2014 · strength 0.04
- Godefridus J. Peters · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.